Pipeline Programs

Blend has been highly productive in generating entirely new classes of platinum drugs as well as other novel molecules with superior therapeutic properties.

Blend’s pipeline includes platinum-based drugs, which are among the most powerful and widely used anticancer therapeutics in use today (see sidebar). Our two lead platinum development programs are: 

  • new mono-functional platinum molecules with a novel mechanism of action
  • new platinum molecules within nanoparticles

In addition, we are applying our proprietary approach to discover and develop other innovative drugs in our pipeline, including:

  • additional targeted new molecules with novel modes of action
  • combination therapy nanomedicines with optimized therapeutic profiles